OPKO Health Inc. (OPK) Reached A New High 4 times During The Past Five Days

As of Thursday close, OPKO Health Inc.’s (NASDAQ:OPK) stock was down -$0.04, moving down -1.64 percent to $2.40. The average number of shares traded per day over the past five days has been 3,467,500 shares. 4 times new highs have been achieved over the past 5 days, with a -$0.03 fall in that time frame. In the last twenty days, the average volume was 2,436,745, while in the previous 50 days, it was 4,221,852.

Since last month, OPK stock retreated -12.41%. Shares of the company fell to $2.31 on 08/01/22, the lowest level in the past month. A 52-week high of $5.25 was reached on 01/03/22 after having rallying from a 52-week low of $2.17. Since the beginning of this year, OPK’s stock price has dropped by -50.10% or -$2.41, and marked a new high 1 time. However, the stock has declined by -54.29% since its 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


OPKO Health Inc. (OPK) last reported insider trading activity 44 days ago on Jun 22. Nabel Gary J., the Chief Innovation Officer of the company, purchased of 240,000 shares for $2.49 on Jun 22. It resulted in a $597,393 investment by the insider. FROST PHILLIP MD ET AL added 200,000 shares at an average price of $2.39 on Jun 21. The insider now owns 196,606,694 shares following the transaction. On Jun 16, CEO & Chairman FROST PHILLIP MD ET AL bought 100,000 shares at $2.31 apiece. The transaction was valued at $231,327.

Valuation Metrics

The stock’s beta is 1.80. Besides these, the trailing price-to-sales (P/S) ratio of 1.10, the price-to-book (PB) ratio of 0.98.

Financial Health

In the three months ended March 30, OPKO Health Inc.’s quick ratio stood at 2.10, while its current ratio was 2.40, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 0.13, and the total debt-to-equity ratio was 0.15. On the profitability front, the trailing twelve-month gross margin is 31.10% percent. In the year ended March 30, operating margins totaled -5.90%. Based on annual data, OPK earned $581.52 million in gross profit and brought in $1.77 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 0.20%. Return on equity (ROE) for the past 12 months was -6.90%.

According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. OPK’s revenue fell -65.59% to $401.33 million during the quarter, while net income inched up to $329.22 million. While analysts expected OPKO Health Inc. to report -$0.06 quarterly earnings, the actual figure was -$0.08 per share, beating the consensus estimate by -33.30%. During the quarter, the company generated -$44.33 million in EBITDA. The liabilities of OPKO Health Inc. were 691.97 million at the end of its most recent quarter ended March 30, and its total debt was $279.51 million. The value of shareholders’ equity is $681.52 million.

Technical Picture

This quick technical analysis looks at OPKO Health Inc.’s (OPK) price momentum. With a historical volatility rate of 37.96%, the RSI 9-day stood at 39.78% on 04 August.

With respect to its five-day moving average, the current OPKO Health Inc. price is down by -1.23% percent or -$0.03. At present, OPK shares trade -14.29% below its 20-day simple moving average and -23.08% percent below its 100-day simple moving average. However, the stock is currently trading approximately -22.58% below its SMA50 and -35.14% below its SMA200.

Stochastic coefficient K was 25.02% and Stochastic coefficient D was 23.54%, while ATR was 0.12. Given the Stochastic reading of 18.77% for the 14-day period, the RSI (14) reading has been calculated as 41.49%. As of today, the MACD Oscillator reading stands at 0.01, while the 14-day reading stands at -0.04.

Analyst Ratings

OPKO Health Inc. downgraded its rating on OPKO Health Inc. (NASDAQ: OPK) to a Mkt perform in a note to investors on January 24, 2022. The analysts firm previously had an Outperform rating on the stock.OPKO Health Inc. (OPK) has been rated Buy by analysts. According to 0 brokerage firms, OPK is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate OPKO Health Inc. stock as buy, with 4 recommending it as overweight.

With a median target price of $6.25, the current consensus forecast for the stock is $5.00 – $8.50. Based on these forecasts, analysts predict OPKO Health Inc. (OPK) will achieve an average price target of $6.50.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Hot Topics

Related Articles

[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]
[class^="wpforms-"]